119-SRES-546 Investigative Journalist Impact Analysis

Summary

What it does: S.Res. 546 designates November 2025 as “National Hospice and Palliative Care Month.” As a simple Senate resolution, it expresses the chamber’s sentiment and does not change law, appropriate funds, or bind agencies. [1]Library of Congress — S.Res.546 — 119th Congress (2025-2026) | Congress.gov[2]U.S. Senate — U.S. Senate: Types of Legislation (Simple Resolutions)

Likely impact: Direct fiscal or regulatory effects are negligible. Indirect effects depend on whether the observance improves timely access to hospice and earlier palliative care. Evidence links such care to better quality of life and, when not initiated in the last few days, lower end‑of‑life costs; yet program integrity issues, ownership incentives, and unequal access remain significant. [4]PubMed / NEJM — Early palliative care for metastatic NSCLC (Temel et al., 2010)[5]JAMA Health Forum — Association Between Hospice Enrollment and Total Health Car…[6]JAMA Internal Medicine (PubMed) — Hospice Length of Stay, Utilization, and Medi…[7]HHS OIG — Hospice Deficiencies Pose Risks to Medicare Beneficiaries[8]U.S. Government Publishing Office — Federal Register (Apr 4, 2023): Hospice mar…[9]Center to Advance Palliative Care — CAPC/NPCRC 2019 State‑by‑State Report Card…

Key numbers above are from MedPAC (beneficiaries, spending, decedent share, provider count), Federal Register (ownership mix), and peer‑reviewed/official estimates of health‑sector emissions. [3]MedPAC — MedPAC March 2024 Report to the Congress, Chapter 9: Hospice services…[8]U.S. Government Publishing Office — Federal Register (Apr 4, 2023): Hospice mar…[10]PubMed / Health Affairs — Health Care Pollution and Public Health Damage in the…

Economic Effects

Direct budget impact is effectively zero; potential downstream effects arise only if public awareness shifts care patterns.

• No direct appropriations or mandatory actions; simple resolutions do not have the force of law. Expected federal budget effect: none. [2]U.S. Senate — U.S. Senate: Types of Legislation (Simple Resolutions)
• Scale: Medicare hospice outlays totaled about $23.7B in 2022 for >1.7M beneficiaries (≈49.1% of decedents). Any utilization shift—even small—occurs against this base. [3]MedPAC — MedPAC March 2024 Report to the Congress, Chapter 9: Hospice services…
• Cost outcomes: Hospice enrollment is associated with lower total costs across payers in the last 3 days to 3 months of life; families’ out‑of‑pocket costs are lower in the last month, with no evidence of cost‑shifting to families. Earlier enrollment (beyond a few days) is key. [5]JAMA Health Forum — Association Between Hospice Enrollment and Total Health Car…
• Timing matters: Very short hospice stays (≤3 days) show little cost difference vs. no hospice, while >15 days is associated with markedly lower utilization and costs in specific populations (e.g., ESRD). Awareness that nudges earlier referrals could therefore strengthen value. [6]JAMA Internal Medicine (PubMed) — Hospice Length of Stay, Utilization, and Medi…
• Market structure: For‑profit hospices comprised ≈74% of providers in FY2022; long stays have been “very profitable,” drawing new entrants, including private equity. Heightened marketing around an awareness month could interact with these incentives. [8]U.S. Government Publishing Office — Federal Register (Apr 4, 2023): Hospice mar…
• Program integrity/oversight: CMS recently tightened hospice enrollment screening (e.g., fingerprinting 5%+ owners) and stood up—but then paused for 2025—the Hospice Special Focus Program. Any utilization uptick without parallel oversight may magnify duplicate payments and quality risks previously flagged by OIG. [11]CMS — CY 2024 Home Health PPS Final Rule (hospice enrollment screening; SFP det…[12]CMS — Hospice Special Focus Program (paused for CY 2025)[13]HHS OIG — Medicare Payments to Nonhospice Providers for Hospice Beneficiaries (…[14]HHS OIG — Safeguards Must Be Strengthened To Protect Medicare Hospice Beneficia…
• Workforce constraint: Nursing and aide shortages persist across post‑acute and home‑based care, which could limit providers’ ability to translate awareness into access without degrading quality or increasing contract‑labor costs. [15]Web search · turn 8 #2

Social Effects

Evidence focuses on patient experience, symptom control, place of death, caregiver outcomes, and equity.

• Quality of life: Randomized evidence shows early palliative care improves quality of life and mood and can reduce aggressive end‑of‑life care; in one cancer trial it also improved survival. Awareness that normalizes early referral may increase these benefits. [4]PubMed / NEJM — Early palliative care for metastatic NSCLC (Temel et al., 2010)
• Patient/caregiver experience: Meta‑analyses and reviews report improved symptom burden and higher odds of dying at home with home‑based palliative models; caregiver outcomes are mixed but bereavement support can modestly reduce grief, depression, and anxiety. [16]Cochrane — Effectiveness and cost‑effectiveness of home‑based palliative care (…[17]Web search · turn 4 #5[18]Web search · turn 8 #1
• Equity gaps: Black beneficiaries use hospice at lower rates than white beneficiaries and often experience more intensive end‑of‑life care; 2022 data show hospice use at death of 51.6% (White) vs. 37.4% (Black). Without targeted outreach, general awareness may widen disparities. [19]Johns Hopkins Medicine — Study documents racial differences in U.S. hospice use…[20]National Alliance for Care at Home — NHPCO/Alliance: 2024 Facts & Figures (high…
• Geography: Access to inpatient palliative teams varies by state and is notably limited in rural hospitals; such gaps could blunt awareness gains for rural populations. [9]Center to Advance Palliative Care — CAPC/NPCRC 2019 State‑by‑State Report Card…

Environmental Effects

The resolution itself has no direct environmental provisions. Any effects would be second‑order via care‑setting shifts.

• Direct impact: None; the measure is symbolic. [2]U.S. Senate — U.S. Senate: Types of Legislation (Simple Resolutions)
• Potential indirects (uncertain, likely small): If awareness contributes to more care at home and less high‑intensity inpatient care at end of life, lifecycle assessments suggest substantially higher emissions per bed‑day in ICUs than home settings; patient travel is also a non‑trivial source. Net sector‑level impact from a one‑month observance is likely de minimis. [21]Medical Journal of Australia (PMC) — Carbon footprint of ICU care (life‑cycle a…[22]JAMA Network Open — Carbon Emissions From Patient Travel for Health Care
• Context: US health care accounts for about 8.5% of national greenhouse gas emissions; decarbonization co‑benefits (e.g., telehealth where appropriate) are policy‑relevant but outside the scope of this resolution. [10]PubMed / Health Affairs — Health Care Pollution and Public Health Damage in the…

Temporal Analysis

Short‑term public attention vs. long‑term system change.

• Near term (0–12 months): Awareness months routinely spike information‑seeking and even screening volumes in analogous areas (e.g., mammography in October). Expect transient media and community activity; measurable hospice utilization changes are uncertain. [23]Health Care Cost Institute — Mammography use peaks in October (HCCI analysis)[24]Health Economics (PubMed) — Awareness campaigns and diagnosis rates (NBCAM stud…
• Medium/long term (1–5 years): Durable effects require reinforcement—training capacity, referral pathways, payment alignment, and oversight. MedPAC notes robust hospice margins and growing utilization, but also non‑hospice spending and oversight needs that policy—not commemoration—must address. [3]MedPAC — MedPAC March 2024 Report to the Congress, Chapter 9: Hospice services…

Unintended Consequences

Risks to monitor if awareness increases demand or marketing intensity.

• Fraud/abuse vectors: New or unscrupulous entrants could leverage awareness marketing; CMS has tightened enrollment screening and (temporarily paused) an SFP to target poor performers—scrutiny should accompany any growth. [11]CMS — CY 2024 Home Health PPS Final Rule (hospice enrollment screening; SFP det…[12]CMS — Hospice Special Focus Program (paused for CY 2025)
• Duplicate/fragmented payments: Significant non‑hospice spending for hospice enrollees (e.g., $6.6B to non‑hospice providers over 2010–2019) shows how benefit design and coordination gaps can waste funds; communications should include coverage education. [13]HHS OIG — Medicare Payments to Nonhospice Providers for Hospice Beneficiaries (…
• Family burden concerns: While some fear cost‑shifting to families, recent analyses show lower out‑of‑pocket costs in the final month with hospice; exceptions can occur with very short stays or inadequate support. [5]JAMA Health Forum — Association Between Hospice Enrollment and Total Health Car…[6]JAMA Internal Medicine (PubMed) — Hospice Length of Stay, Utilization, and Medi…
• Equity backlash: Without culturally tailored messaging and community partners, general campaigns may increase awareness primarily among groups already well served, widening gaps seen by race and rurality. [19]Johns Hopkins Medicine — Study documents racial differences in U.S. hospice use…[9]Center to Advance Palliative Care — CAPC/NPCRC 2019 State‑by‑State Report Card…

Assessment

Overall stance: Neutral. The resolution is symbolic; on its own, it is unlikely to materially change economic, social, or environmental outcomes. The most plausible benefits are incremental—public literacy, earlier conversations, and modest shifts toward timely palliative involvement—whose value depends on concurrent actions on training, equity outreach, and program integrity already flagged by CMS, MedPAC, and OIG. [2]U.S. Senate — U.S. Senate: Types of Legislation (Simple Resolutions)[3]MedPAC — MedPAC March 2024 Report to the Congress, Chapter 9: Hospice services…[11]CMS — CY 2024 Home Health PPS Final Rule (hospice enrollment screening; SFP det…[7]HHS OIG — Hospice Deficiencies Pose Risks to Medicare Beneficiaries

Sourcing

Key references underpinning this assessment (selected):

• Measure text and status: Congress.gov (S.Res. 546 agreed to in Senate, Dec 16, 2025). [1]Library of Congress — S.Res.546 — 119th Congress (2025-2026) | Congress.gov
• Nature of simple resolutions (no force of law): US Senate glossary and briefings. [2]U.S. Senate — U.S. Senate: Types of Legislation (Simple Resolutions)
• Utilization, spending, margins: MedPAC March 2024, Hospice chapter. [3]MedPAC — MedPAC March 2024 Report to the Congress, Chapter 9: Hospice services…
• Cost/financial outcomes: JAMA Health Forum 2022 (insurers and families); NORC 2023 (Medicare). [5]JAMA Health Forum — Association Between Hospice Enrollment and Total Health Car…[25]Web search · turn 2 #5
• Timing sensitivity: JAMA Internal Medicine 2018 (ESRD hospice LOS and costs). [6]JAMA Internal Medicine (PubMed) — Hospice Length of Stay, Utilization, and Medi…
• Clinical outcomes: NEJM 2010 (early palliative care RCT); Cochrane reviews of home‑based palliative care. [4]PubMed / NEJM — Early palliative care for metastatic NSCLC (Temel et al., 2010)[16]Cochrane — Effectiveness and cost‑effectiveness of home‑based palliative care (…
• Equity/disparities: Johns Hopkins (racial differences) and NHPCO Facts & Figures 2024 (race‑stratified hospice use). [19]Johns Hopkins Medicine — Study documents racial differences in U.S. hospice use…[20]National Alliance for Care at Home — NHPCO/Alliance: 2024 Facts & Figures (high…
• Access variation: CAPC State‑by‑State report card (rural and state gaps). [9]Center to Advance Palliative Care — CAPC/NPCRC 2019 State‑by‑State Report Card…
• Market/ownership dynamics: Federal Register 2023 (for‑profit share; private equity). [8]U.S. Government Publishing Office — Federal Register (Apr 4, 2023): Hospice mar…
• Oversight and integrity: CMS HH PPS 2024 (screening; SFP) and CMS SFP pause notice; OIG 2019–2022 (deficiencies; harm; duplicate payments). [11]CMS — CY 2024 Home Health PPS Final Rule (hospice enrollment screening; SFP det…[12]CMS — Hospice Special Focus Program (paused for CY 2025)[7]HHS OIG — Hospice Deficiencies Pose Risks to Medicare Beneficiaries[14]HHS OIG — Safeguards Must Be Strengthened To Protect Medicare Hospice Beneficia…[13]HHS OIG — Medicare Payments to Nonhospice Providers for Hospice Beneficiaries (…
• Environmental context: Health‑sector emissions and ICU footprints; patient‑travel emissions. [10]PubMed / Health Affairs — Health Care Pollution and Public Health Damage in the…[21]Medical Journal of Australia (PMC) — Carbon footprint of ICU care (life‑cycle a…[22]JAMA Network Open — Carbon Emissions From Patient Travel for Health Care
• Awareness month effects (analogous): Mammography peaks and diagnosis spillovers. [23]Health Care Cost Institute — Mammography use peaks in October (HCCI analysis)[24]Health Economics (PubMed) — Awareness campaigns and diagnosis rates (NBCAM stud…